ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MicroRNA-10a/b inhibit TGF-β/Smad-induced renal fibrosis by targeting TGF-β receptor 1 in diabetic kidney disease

Li, Jinxiang; Yue, Shuling; Fang, Jingwen; Zeng, Junling; Chen, Siqi; Tian, Jianwei; Nie, Sheng; Liu, Xiaoting; Ding, Hanying*南方医科大学
Molecular Therapy-Nucleic Acids2022-3-15DOI: 10.1016/j.omtn.2022.04.002
13被引7阅读
引用收藏
分享

摘要

TGF-beta/Smad signaling plays a vital role in the development of fibrosis in diabetic kidney disease (DKD). However, remedies targeting key elements in TGF-beta/Smad signaling are lacking. Here, we found that TGF-beta receptor 1 (TGFBR1), a key protein in TGF-beta/Smad signaling, was upregulated in kidney from diabetic mice and patients with DKD. Induction of TGFBR1 was regulated by microRNA-10a and -10b (miR-10a/b) by a post-transcriptional mechanism. Furthermore, the decreased XRN2, an exoribonuclease, was identified to contribute to affecting miR-10a/b maturation in vitro. In streptozotocin (STZ)-induced DKD mice, preventing the reduction of miR-10a/b in the kidney by an in situ lentivirus-injection method attenuated collagen deposition and foot process effacement, whereas deprivation of miR-10a/b aggravated renal fibrosis. Mechanistically, manipulating miR-10a/b in the kidney influenced TGFBR1 protein expression, TGF-beta/Smad signaling activation, and downstream pro-fibrotic genes expression including fibronectin (FN) and alpha-smooth muscle actin (alpha-SMA). In a cohort of patients diagnosed DKD, renal miR-10a/b expressions were downregulated, whereas both TGFBR1 and fibrosis were enhanced. Our finding suggests that overexpressing miR-10a/b in kidney may be a promising method for the treatment of fibrosis in DKD.

学科与关键词

关键词
NEPHROPATHYPROTEININFLAMMATIONACTIVATIONINJURYSMAD
相关
加载中…
  • miR-23a-3p regulates the inflammatory response and fibrosis in diabetic kidney disease by targeting early growth response 1
    Sheng, Shuyue; Zou, Meina; Yang, Yanlin; Guan, Meiping; Ren, Shijing; Wang, Xiangyu; Wang, Ling; Xue, Yaoming*In Vitro Cellular and Developmental Biology - Animal, 2021, 57(8): 763-774.被引 12
  • MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome
    Ding, Hanying; Li, Jinxiang; Li, Yang; Yang, Minliang; Nie, Sheng; Zhou, Miaomiao; Zhou, Zhanmei; Yang, Xiaobing; Liu, Youhua; Hou, Fan Fan*Molecular Therapy, 2021, 29(7): 2308-2320.被引 35
  • Endophilin A2 protects against renal fibrosis by targeting TGF-β/Smad signaling
    Mai, Xiaoyi*; Shang, Jinyan; Chen, Qiuyuan; Gu, Shijie; Hong, Yu; Zhou, Jiaguo; Zhang, Minzhou*FASEB Journal, 2022, 36(11): e22603.
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Therapy-Nucleic Acids
发表日期
2022-03-15
卷期
第 28 卷
页码
488-499
DOI
10.1016/j.omtn.2022.04.002
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81700640, 81970608]

作者

  • L

    Li, Jinxiang (第一作者)

    southern med univ

  • Y

    Yue, Shuling

查看全部 9 位作者收起作者
  • F

    Fang, Jingwen

    southern med univ

  • Z

    Zeng, Junling

    southern med univ

  • C

    Chen, Siqi

    southern med univ

  • T

    Tian, Jianwei

    southern med univ

  • N

    Nie, Sheng

    southern med univ

  • L

    Liu, Xiaoting

  • D

    Ding, Hanying (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417